New JerseyS4194221st Legislature (2026-2027)Senate

Revises certain requirements for prescription of Schedule II controlled dangerous substances via telemedicine and telehealth without in-person examination or review.*

Sponsored By: Vin Gopal (Democratic), Raj Mukherji (Democratic), Joseph F. Vitale (Democratic)

Failed

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & Cosponsors

Sponsors

  • Vin Gopal

    Democratic • Senate

  • Raj Mukherji

    Democratic • Senate

  • Joseph F. Vitale

    Democratic • Senate

Cosponsors

There are no cosponsors for this bill.

Roll Call Votes

No roll call votes available for this bill.

Actions Timeline

  1. Substituted by A4852 (ACS)

    6/30/2026Senate
  2. REP/SCS, 2nd Reading in Senate

    6/11/2026Senate
  3. Introduced, 1st Reading in Senate, Referred to Senate Health, Human Services and Senior Citizens Committee

    5/11/2026Senate

Bill Text

  • Senate Health, Human Services and Senior Citizens (6/11/26 SCS S4210)

    6/12/2026

  • Senate Health, Human Services and Senior Citizens Substitute (6/11/26 SCS S4210)

    6/12/2026

  • As Introduced

    5/12/2026

Related Bills

Back to State Legislation